Search results for

In a guest post, IEEE Managing Director Konstantinos Karachalios responds to criticisms of its updated patent policy

Zoledronic acid hydrate (zoledronate) is a medicinal compound created by Novartis and is also an active substance of the bone resorption inhibitor named Zometa for i v infusion. Novartis filed a Japanese patent application including the claimed invention as follows: "An agent for treatment containing 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid (Zoledronate) or pharmaceutically acceptable salts, wherein 4 mg of Zoledronate is to be administered intravenously over a period of 15 minutes to a patient in need of bisphosphonate treatment."

Fluke, Spectrum Brands, Harley-Davidson, Conair and InterContinental Hotels reveal how traffic light systems and brainstorming with marketing can help them through the trademark registration process

Lawyers react as Turkey’s Supreme Court ends years of speculation caused by the transition from one IP law to another by ruling that trademarks can be cancelled retroactively

Managing IP rounds up the latest patent, trademark and copyright news, including some stories you might have missed

Laura Whiting and Alexandra Morgan of Freshfields Bruckhaus Deringer consider the reasons behind the adoption of the new SPC Manufacturing Waiver Regulation and reflect on whether the message sent out by the European institutions is consistent with their trade policy

Managing IP invites its in-house counsel readers to take its survey on patenting AI, patenting AI-invented innovations and how AI could streamline the patenting process. Help inform the industry and, in the process, inform yourselves

The Rising Stars Awards releases its winners for the 2021 Americas awards

Counsel from AstraZeneca and other pharma sources say uncertainties loom around how China’s three-month-old patent linkage system will work

The US’s patent appellate court accepts very few petitions for rehearings, as new data reveals, but it won’t deter some counsel from trying